At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 7 enrolled
Drug / intervention
Esmololdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Esmolol to Control Adrenergic Storm in Septic Shock - Roll-in
In Brief
A Phase 2 clinical trial evaluating Esmolol for Septic Shock. Completed, enrolled 7 participants across 1 site.
Detailed Summary
This is a prospective, single arm, "roll-in" study of esmolol infusion for patients with septic shock with persistent tachycardia after adequate intravenous volume expansion. The study will evaluate the adequacy and efficiency of study protocols for the anticipated, main ECASSS study, which will have a separate entry in clinicaltrials.gov.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeptic Shock
CountriesUnited States
CollaboratorsBeth Israel Deaconess Medical Center
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedJul 2016
Primary CompletionMar 2017
TodayJul 2026
First PostedJul 22, 2016
Enrollment StartApr 1, 2016
Primary CompletionMar 1, 2017
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 9.9 years ago
Interventions
Esmololdrug
Esmolol infusion